Status:
RECRUITING
Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Oncologic Complications and Emergencies
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.
Detailed Description
Primary Objectives: \- The rate of catheter failure, defined as removal of the catheter for any reason other than "Care Complete" (i.e. a composite of removal due to "infiltration," "leaking," "cathe...
Eligibility Criteria
Inclusion
- Age \> 18 years old.
- Provision of signed and dated informed consent form.
- Predetermined to have difficult IV access necessitating USIV placement
- Expected admission to hospital with anticipated stay \> 48 hours (per discussion with treating physician).
Exclusion
- Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician).
- Inability to give informed consent.
- Pregnant women.
- Non-English speaking participants.
Key Trial Info
Start Date :
March 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06217783
Start Date
March 27 2024
End Date
December 1 2027
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030